{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:10:10Z","timestamp":1748477410623,"version":"3.41.0"},"reference-count":27,"publisher":"Georg Thieme Verlag KG","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1055\/a-2359-4422","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T23:45:43Z","timestamp":1748475943000},"page":"741-746","source":"Crossref","is-referenced-by-count":0,"title":["Antithrombotische Therapie bei polyvaskul\u00e4rer Atherosklerose"],"prefix":"10.1055","volume":"150","author":[{"given":"Christine","family":"Espinola-Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"L Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/eurheartj\/ehv006","article-title":"Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence","volume":"36","author":"H Reinecke","year":"2015","journal-title":"Eur Heart J"},{"issue":"S 113","key":"ref3","first-page":"1","article-title":"S3-Leitlinie zur Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit","volume":"54","author":"N Malyar","year":"2025","journal-title":"Vasa"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"C Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2020.11.001","article-title":"Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy","volume":"315","author":"EH Weissler","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1093\/eurheartj\/ehab390","article-title":"Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy","volume":"42","author":"V Aboyans","year":"2021","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease","volume":"376","author":"WR Hiatt","year":"2017","journal-title":"N Engl J Med"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5239","article-title":"Polyvascular Diseaseand Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease A Secondary Analysis of the EUCLID Trial","volume":"1","author":"A Gutierrez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"DL Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"L Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"MP Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","article-title":"Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease","volume":"67","author":"MP Bonaca","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa1908077","article-title":"Ticagrelor in Patients with Stable Coronary Disease and Diabetes","volume":"381","author":"PG Steg","year":"2019","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"MT Roe","year":"2012","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents","volume":"371","author":"L Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/eurheartj\/ehac460","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"DA Morrow","year":"2012","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.115.019355","article-title":"Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease. Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis \u2013 Thrombolysis in Myocardial Infarction 50 (TRA2 \u00b0P-TIMI 50)","volume":"133","author":"MP Bonaca","year":"2016","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ahj.2014.06.017","article-title":"Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in acute coronary syndrome (TRACER)","volume":"168","author":"WS Jones","year":"2014","journal-title":"Am Heart J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","article-title":"Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease","volume":"357","author":"The Warfarin Antiplatelet Vascular Evaluation Trial Investigators","year":"2007","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1105819","article-title":"Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome","volume":"365","author":"JH Alexander","year":"2011","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in Patients with a Recent Acute Coronary Syndrome","volume":"366","author":"JL Mega","year":"2012","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease","volume":"377","author":"JW Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"SS Anand","year":"2018","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in Peripheral Artery Disease after Revascularization","volume":"382","author":"MP Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1161\/CIRCULATIONAHA.120.050465","article-title":"Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety","volume":"142","author":"WR Hiatt","year":"2020","journal-title":"Circulation"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2359-4422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T23:45:50Z","timestamp":1748475950000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2359-4422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":27,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,5,28]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["a23594422"],"URL":"https:\/\/doi.org\/10.1055\/a-2359-4422","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]}}}